Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Dyslipidemia

  Free Subscription


19.05.2025

1 Clin Cardiol
1 Eur J Clin Nutr
4 J Am Coll Cardiol
1 Metabolism
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Clin Cardiol

  1. KI YJ, Kim W, Lee KH, Han SJ, et al
    Lipid-Lowering Effect and Safety of Ezetimibe and Atorvastatin 5 mg in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia: A Randomized, Double-Blind, Parallel, Multicenter, Phase 3 Clinical Trial.
    Clin Cardiol. 2025;48:e70138.
    PubMed         Abstract available


    Eur J Clin Nutr

  2. XU J, Xie L, Fan R, Shi X, et al
    The role of dietary inflammatory index in metabolic diseases: the associations, mechanisms, and treatments.
    Eur J Clin Nutr. 2024 Oct 21. doi: 10.1038/s41430-024-01525.
    PubMed         Abstract available


    J Am Coll Cardiol

  3. NORDESTGAARD AT, Tybjaerg-Hansen A, Mansbach H, Kersten S, et al
    Target Populations for Novel Triglyceride-Lowering Therapies.
    J Am Coll Cardiol. 2025;85:1876-1897.
    PubMed         Abstract available

  4. XIE X, Shi X, Zhang Y, Su S, et al
    Angiopoietin-Like 3 Antibody Therapy in Patients With Suboptimally Controlled Hyperlipidemia: A Phase 2 Study.
    J Am Coll Cardiol. 2025;85:1821-1835.
    PubMed         Abstract available

  5. RAY KK, Linnebjerg H, Michael LF, Shen X, et al
    Effect of ANGPTL3 Inhibition With Solbinsiran in Preclinical and Early Human Studies.
    J Am Coll Cardiol. 2025;85:1803-1818.
    PubMed         Abstract available

  6. BALLANTYNE CM, Gaudet D, Rosenson RS, Hegele RA, et al
    Effect of Targeting ApoC-III With Plozasiran on Lipoprotein Particle Size and Number in Hypertriglyceridemia.
    J Am Coll Cardiol. 2025;85:1839-1854.
    PubMed         Abstract available


    Metabolism

  7. WANG Y, Wu Y, Jiang H, Li S, et al
    L-Kynurenine activates the AHR-PCSK9 pathway to mediate the lipid metabolic and ovarian dysfunction in polycystic ovary syndrome.
    Metabolism. 2025;168:156238.
    PubMed         Abstract available


    PLoS One

  8. ZHONG Q, Ren L, Wang T, An Z, et al
    The association between circadian syndrome and possible sarcopenia in an aging population: A 4-year follow-up study.
    PLoS One. 2025;20:e0323211.
    PubMed         Abstract available

  9. CHOI J, Kim J, Oh HS
    Relationship between insulin resistance surrogate markers with diabetes and dyslipidemia: A Bayesian network analysis of Korean adults.
    PLoS One. 2025;20:e0323329.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Dyslipidemia is free of charge.